Atlas Trials

Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

Clinical trial NCT00671710 · COMPLETED

Trial details

NCT number
NCT00671710
Sponsor
Advocate Hospital System
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Brain Tumors
Start date
2008-04-01
Primary completion
2010-11-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.